2022 · British journal of clinical pharmacology · open access
Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients
Zwart et al.
The finding, in our words
Validated a dried blood spot assay for tacrolimus and mycophenolic acid therapeutic drug monitoring and creatinine-based kidney function in kidney transplant recipients. DBS showed excellent agreement with venous sampling for tacrolimus trough and AUC, adequate agreement for creatinine-based GFR trend monitoring, but suboptimal agreement for mycophenolic acid AUC and inadequate performance for iohexol-based GFR. VAMS was generally inferior. This enables remote, simultaneous immunosuppressant and kidney function monitoring in outpatients, reducing clinic visits.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.